Dr. Phay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2050 Kenny Rd
Columbus, OH 43221Phone+1 614-293-7171Fax+1 614-293-3465
Summary
- Dr. John Phay is an endocrine surgeon in Columbus, OH and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute, Ohio State University Wexner Medical Center. He received his medical degree from University of California San Francisco School of Medicine and has been in practice 24 years. He specializes in endocrine, surgical oncology (other than breast), and minimally invasive surgery and is experienced in thyroid cancer, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hyperparathyroidism.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 1993 - 2002
- University of California San Francisco School of MedicineClass of 1993
Certifications & Licensure
- OH State Medical License 2009 - 2026
- TN State Medical License 2002 - 2010
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery Start of enrollment: 2018 Apr 23
Publications & Presentations
PubMed
- 41 citationsUpdate on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheoc...Dhaval Patel, John E. Phay, Tina W.F. Yen, Paxton V. Dickson, Tracy S. Wang
Annals of Surgical Oncology. 2020-02-28 - 152 citationsCloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9).John E. Phay, Hameda B. Hussain, Jeffrey F. Moley
Genomics. 2000-06-01 - 311 citationsThe impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.Victor M. Zaydfudim, Irene D. Feurer, Marie R. Griffin, John E. Phay
Surgery. 2008-12-01
Journal Articles
- Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma DatabaseJohn Phay, Lawrence A Shirley, Lauren M Postlewait, Carmen C Solorzano, Colleen M Kiernan, Ioannis Hatzaras, Natalie Seiser, Tracy S Wang, Ryan C Fields, Konstantinos ..., Annals of Surgical Oncology
Press Mentions
- Characterizing the Function of EPB41L4A in the Predisposition to Papillary Thyroid CarcinomaNovember 17th, 2020
- Characterizing the Function of EPB41L4A in the Predisposition to Papillary Thyroid CarcinomaNovember 17th, 2020
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: